Amplify Treatments, Testing And Advancements ETF ALNY Holdings History
Amplify Treatments, Testing and Advancements ETF's Alnylam Pharmaceuticals Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 3,931.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $955,230.00. This investment constitutes 10.46% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $157.87 for 414.00 shares. Based on historical transaction data and ALNY's current price of $320.53, Amplify Treatments, Testing and Advancements ETF's estimated gain on his ALNY holdings is $600,528.71, reflecting a 82.85% gain to date.
Amplify Treatments, Testing and Advancements ETF ALNY ($320.53) Holding Chart
Amplify Treatments, Testing and Advancements ETF ALNY ($320.53) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
